Collectively, ZHX2 protects hepatocytes from abnormal lipid deposition in NAFLD through transcriptional repression of LPL, which subsequently retards cell growth and NAFLD–HCC progression. The gene discussed is LPL; the disease is metabolic dysfunction-associated steatotic liver disease.